Skip to main content
Formula Atlas
Ingredient explainer

Metafolin vs Folic Acid

Most infant formulas fortify with folic acid (the synthetic oxidized form of folate). HiPP uses Metafolin - the reduced, active form that bypasses the MTHFR enzymatic step. For infants with MTHFR gene variants (roughly 10-15% of the US population are homozygous for the 677TT variant), Metafolin is more efficiently utilized. The EU and US both permit both forms; the choice is a brand positioning decision.

By María López Botín· Last reviewed
Metafolin vs Folic Acid
Category
vitamin
Role in formula
Bioavailable form of folate (vitamin B9) used preferentially by HiPP and some specialty formulas; bypasses the MTHFR enzymatic conversion required for folic acid
Health rating
5/5
EU regulatory status
permitted
US regulatory status
permitted
Synonyms
L-5-MTHF, (6S)-5-methyltetrahydrofolate, calcium L-methylfolate, calcium levomefolate
By María López Botín · Mother of 2, researching infant formula and infant nutrition since 2018

Metafolin is one of the quiet differentiators of HiPP infant formulas, a small but real edge that rarely gets discussed in parenting forums and almost never gets explained properly. The question isn't whether your baby needs folate (every infant does, folate is vitamin B9, essential for DNA synthesis, red blood cell formation, and neural development). The question is what form of folate is in the formula, and whether that form matters. For most babies it doesn't. For the 10–15% with specific MTHFR gene variants, it can.

The two forms of folate in infant formula

Folate exists naturally in food as a family of related molecules, collectively the B9 vitamin. In fortified foods and supplements, two specific forms are used:

  • Folic acid. The fully oxidized synthetic form. Cheap, stable, effective for most people. Used in essentially every US and EU fortified food program since the 1990s. Requires metabolic activation through the MTHFR enzyme (methylene- tetrahydrofolate reductase) to become the biologically active L-5-MTHF form.
  • Metafolin / L-5-MTHF. The already-active, reduced form. No MTHFR conversion required. Bioidentical to the folate circulating in human blood and the folate found naturally in breast milk and leafy greens.

Both are legally permitted as folate sources in infant formula under both EU Regulation 2016/127 and US FDA 21 CFR 107. The choice is at the brand's discretion.

Folate metabolism pathway showing why Metafolin (L-5-methyltetrahydrofolate) bypasses MTHFR enzyme conversion that folic acid requires, and why MTHFR gene variants matter for folate bioavailability
Folic acid requires conversion by the MTHFR enzyme to become bioactive L-5-MTHF. 40-60% of people carry MTHFR variants that reduce conversion efficiency. Metafolin is already in the bioactive form, it bypasses the enzymatic step entirely.

Visual generated with Napkin AI, editorial review by María López Botín. See methodology for our use policy.

The MTHFR question

The MTHFR enzyme has a common polymorphism, the C677T variant, that reduces enzyme activity. People with the TT genotype (homozygous for the variant) have roughly 30–40% of normal MTHFR function. People with the CT genotype (heterozygous) have about 65–70%. The prevalence varies by population:

  • Non-Hispanic white US: ~12% TT, ~42% CT
  • Hispanic US: ~21% TT, ~47% CT
  • African American US: ~2% TT, ~25% CT
  • European populations: varies widely, generally 10–20% TT

For people with reduced MTHFR function, folic acid supplementation works less efficiently because the conversion step is slowed. They still get enough folate for most purposes, but the conversion bottleneck is real and measurable. L-5-MTHF (Metafolin) bypasses this step entirely.

Does this matter for a healthy infant?

Clinically, for the average formula-fed baby: the difference between folic acid and Metafolin is small. Folic acid is effective, safe, and adequate at the fortification levels used in infant formula. The infant's MTHFR enzyme, even with a variant, gets enough substrate through and maintains folate status.

The cases where it matters more:

  • Infants with MTHFR TT who also have suboptimal folate intake from other sources. Rare but theoretically relevant.
  • Parents of MTHFR-variant infants who are themselves aware of the polymorphism and want to optimize early nutrition. A minority but vocal group in the parenting-forum world.
  • Long-term health signaling. Some researchers argue that lifetime exposure to unmetabolized folic acid (UMFA), the synthetic form that hasn't been converted , may have independent effects on methylation, epigenetics, or cancer risk. This is contested and the evidence is not definitive.

Which formulas use which

  • HiPP across its product lines uses calcium L-methylfolate (Metafolin) rather than folic acid. Our HiPP Dutch Stage 1 record confirms this, and the full HiPP brand hub details this across the Dutch, German, and UK lines. HiPP has positioned Metafolin as a deliberate differentiator for years.
  • Holle historically uses folic acid, though their newer biodynamic line has been reformulated.
  • Kendamil uses folic acid in standard formulations.
  • Most US major brands (Similac, Enfamil, Bobbie) use folic acid.
  • Specialty or "premium" US formulas occasionally use L-methylfolate.

A parent specifically wanting Metafolin for MTHFR reasons or for theoretical optimization will find HiPP the most widely available option in the US-import channel. Our Infant Formula Atlas lets you cross-reference by folate form as additional SKU records are documented.

Evidence summary

  • Bioavailability. L-5-MTHF is bioavailable for everyone; folic acid is bioavailable for people with normal MTHFR function but less efficient for variant carriers. Trials in adults show L-5-MTHF produces more stable blood folate levels than equivalent folic acid doses.
  • Infant-specific trials. There are few head-to-head trials comparing the two forms specifically in formula-fed infants. The EFSA scientific opinion on L-methylfolate calcium salt (2004) concluded it is a safe and effective folate source in infant nutrition, comparable to folic acid in healthy infants.
  • No documented harm from either form at infant-formula fortification levels.

What a parent should actually do

If your pediatrician hasn't flagged a folate or MTHFR concern, both forms work and the difference is small. If you know you or your baby's other parent has an MTHFR variant, or if you prefer to match the breast-milk folate form as closely as possible on principle, HiPP is the straightforward choice among widely-available formulas.

The decision is one of those optimization questions that matters to a minority of parents but is very meaningful to that minority. Our documentation exists to make the choice visible rather than to push either answer.

Frequently asked questions

What's the difference between Metafolin and folic acid?
Folic acid is the synthetic, oxidized form of folate that requires conversion to active forms (specifically 5-MTHF) by enzymes including MTHFR (methylenetetrahydrofolate reductase). Metafolin (L-5-methyltetrahydrofolate calcium salt) is the bioactive form that doesn't require conversion — it's directly usable by the body. About 40-60% of the population has MTHFR genetic variants that reduce folic acid conversion efficiency by 30-70%, depending on variant. Metafolin bypasses this conversion entirely.
Which infant formulas use Metafolin?
HiPP (German Combiotik line, Dutch line) is the most prominent infant formula using Metafolin instead of folic acid as the standard folate source. Some other premium European formulas use Metafolin in select variants. Most US formulas (Similac, Enfamil, Bobbie, ByHeart, basic Earth's Best) and many EU formulas continue using folic acid. The Atlas SKU records document folate form where labeled.
Does my baby need Metafolin if neither parent has MTHFR variants?
Probably not. Without MTHFR variants, folic acid conversion to active 5-MTHF proceeds normally, and folic acid in formula is bioactivated efficiently. The clinical difference between formulas using folic acid vs Metafolin is small for typical genetic profiles. Metafolin matters most for parents with confirmed MTHFR variants (homozygous C677T or compound heterozygous), where conversion efficiency is significantly reduced.
How do I know if I or my baby has MTHFR variants?
Genetic testing — direct-to-consumer (23andMe, AncestryDNA) reports MTHFR status, or clinical genetic testing through a healthcare provider. About 40-60% of people have at least one MTHFR variant; severe homozygous variants are less common but present in significant minority populations. Some pediatricians screen for MTHFR; others don't unless there's specific clinical indication. If you've never been tested, you don't know your status — but most people get adequate folate from folic acid regardless of variant status.
Is folic acid harmful?
No, folic acid in infant formula at regulated concentrations is not harmful. The 'unmetabolized folic acid' concern (UMFA — high doses of folic acid that bypass enzymatic conversion and circulate in their unaltered form) is theoretically problematic but unlikely at infant formula concentrations. FDA, EFSA, and AAP all consider folic acid in infant formula safe and adequate. The Metafolin alternative is positioned as 'optimal' rather than 'necessary.'
Does breast milk contain Metafolin or folic acid?
Breast milk contains folate primarily in the active 5-MTHF form (the same form as Metafolin) — derived from the mother's metabolized folate. So Metafolin-fortified formulas more closely match breast milk's folate form than folic acid-fortified formulas. This is part of the rationale for HiPP's use of Metafolin: closer-to-breast-milk nutrient delivery. Breast milk also contains other folate forms in smaller amounts.

Primary sources

  1. Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica 2014, bioavailability and metabolism review. pubmed.ncbi.nlm.nih.gov/31852059
  2. EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food. Scientific opinion on calcium L-methylfolate as source of folate in food, EFSA Journal 2004. efsa.europa.eu
  3. Yafei W et al. MTHFR C677T polymorphism prevalence. Gene 2012. pubmed.ncbi.nlm.nih.gov/19926955
  4. EU Commission Delegated Regulation 2016/127, permits calcium L-methylfolate and folic acid as folate sources. eur-lex.europa.eu

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.

Formulas containing metafolin vs folic acid

Primary sources

  1. L-5-MTHF (Metafolin) vs folic acid in infant nutrition: bioavailability review. https://pubmed.ncbi.nlm.nih.gov/31852059/
  2. EFSA scientific opinion on L-methylfolate calcium salt as food ingredient. https://www.efsa.europa.eu/en/efsajournal/pub/2069
  3. MTHFR polymorphism prevalence in infant populations. https://pubmed.ncbi.nlm.nih.gov/19926955/
  4. EU Commission Delegated Regulation 2016/127 - permits both folate forms. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32016R0127

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.